CoChat

Conditional Knockout of Hypoxia-Inducible Factor 1-Alpha in Tumor-Infiltrating Neutrophils Protects against Pancreatic Ductal Adenocarcinoma

Open access

The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.

Abstract

Large numbers of neutrophils infiltrate tumors and comprise a notable component of the inflammatory tumor microenvironment. While it is established that tumor cells exhibit the Warburg effect for energy production, the contribution of the neutrophil metabolic state to tumorigenesis is unknown. Here, we investigated whether neutrophil infiltration and metabolic status promotes tumor progression in an orthotopic mouse model of pancreatic ductal adenocarcinoma (PDAC). We observed a large increase in the proportion of neutrophils in the blood and tumor upon orthotopic transplantation. Intriguingly, these tumor-infiltrating neutrophils up-regulated glycolytic factors and hypoxia-inducible factor 1-alpha (HIF-1α) expression compared to neutrophils from the bone marrow and blood of the same mouse. This enhanced glycolytic signature was also observed in human PDAC tissue samples. Strikingly, neutrophil-specific deletion of HIF-1α (HIF-1αΔNφ) significantly reduced tumor burden and improved overall survival in orthotopic transplanted mice, by converting the pro-tumorigenic neutrophil phenotype to an anti-tumorigenic phenotype. This outcome was associated with elevated reactive oxygen species production and activated natural killer cells and CD8+ cytotoxic T cells compared to littermate control mice. These data suggest a role for HIF-1α in neutrophil metabolism, which could be exploited as a target for metabolic modulation in cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms24010753

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Pro-tumoral neutrophils infiltrate the pancreas of tumor-bearing mice and their persistent depletion improves tumor outcomes (a) Pancreatic tumors were harvested from day 28 tumor-bearing orthotopic transplanted (OT) mice, and the composition of the myeloid cell populations was assessed by flow cytometry. Scatter plot of neutrophils [Dapi-CD45 + Lin(CD3/B220/NK1.1) − Ly6G + Ly6C+] that infiltrate the pancreas are plotted as a percentage of total CD45+ cells, from OT (open circles) and age-matched sham non-tumor bearing controls (black circles). OT n = 15–17, sham n = 10; pooled from three independent experiments. (b) OT and control mice pancreata sections were stained for Dapi (blue) and Ly6G (red) expression. Representative immunofluorescence and H&E images of n = 3 experiments for each group. Scale bar = 100 µM. (c–e) Orthotopic tumors were generated in CXCR2−/− (blue circles) or control (black circles) mice. (c) Neutrophil infiltration into the pancreas was monitored at 6, 21 and 28 days post transplantation (CXCR2−/− n = 4, controls n = 7 per experiment for each time point). (d) Scatter plot of orthotopic tumor weights at 6, 14, 21, 28 and 35 days post transplantation (n = 3 mice per experiment for each time point). (e) Kaplan–Meier survival analysis of CXCR2−/− OT mice compared with control OT mice (n = 10). (f,g) OT mice were treated with α Ly-6G antibody (green) or isotype control antibody (black) via intraperitoneal (i.p.) injection thrice per week. (f) Neutrophil infiltration into the pancreas (plotted as a percentage of total CD45+ cells) was monitored at 6, 21 and 28 days post transplantation (n = 3–5 mice per experiment for each time point). (g) Scatter plot of orthotopic tumor weights at 6, 14, 21, 28 and 35 days post transplantation (n = 3 mice per experiment for each time point). (h) Kaplan–Meier survival analysis of α Ly-6G treated mice compared with isotype control treated mice (n = 10). Data represent the means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by unpaired student’s t-test with a 95% confidence interval.
Figure 1 Pro-tumoral neutrophils infiltrate the pancreas of tumor-bearing mice and their persistent depletion improves tumor outcomes (a) Pancreatic tumors were harvested from day 28 tumor-bearing orthotopic transplanted (OT) mice, and the composition of the myeloid cell populations was assessed by flow cytometry. Scatter plot of neutrophils [Dapi-CD45 + Lin(CD3/B220/NK1.1) − Ly6G + Ly6C+] that infiltrate the pancreas are plotted as a percentage of total CD45+ cells, from OT (open circles) and age-matched sham non-tumor bearing controls (black circles). OT n = 15–17, sham n = 10; pooled from three independent experiments. (b) OT and control mice pancreata sections were stained for Dapi (blue) and Ly6G (red) expression. Representative immunofluorescence and H&E images of n = 3 experiments for each group. Scale bar = 100 µM. (c–e) Orthotopic tumors were generated in CXCR2−/− (blue circles) or control (black circles) mice. (c) Neutrophil infiltration into the pancreas was monitored at 6, 21 and 28 days post transplantation (CXCR2−/− n = 4, controls n = 7 per experiment for each time point). (d) Scatter plot of orthotopic tumor weights at 6, 14, 21, 28 and 35 days post transplantation (n = 3 mice per experiment for each time point). (e) Kaplan–Meier survival analysis of CXCR2−/− OT mice compared with control OT mice (n = 10). (f,g) OT mice were treated with α Ly-6G antibody (green) or isotype control antibody (black) via intraperitoneal (i.p.) injection thrice per week. (f) Neutrophil infiltration into the pancreas (plotted as a percentage of total CD45+ cells) was monitored at 6, 21 and 28 days post transplantation (n = 3–5 mice per experiment for each time point). (g) Scatter plot of orthotopic tumor weights at 6, 14, 21, 28 and 35 days post transplantation (n = 3 mice per experiment for each time point). (h) Kaplan–Meier survival analysis of α Ly-6G treated mice compared with isotype control treated mice (n = 10). Data represent the means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by unpaired student’s t-test with a 95% confidence interval.CC BY · PubMed Central
Figure 2 Pro-tumoral neutrophils exhibit a highly glycolytic signature and are adapted to a hypoxic tumor microenvironment (a–e) Bone marrow (BM), blood and tumor neutrophils were sorted based on their expression of Dapi-CD45 + Lin(CD3/B220/NK1.1) − Ly6G + Ly6C+ (orthotopic transplanted [OT] n = 5 mice pooled, three independent experiments). Hierarchical clustering and principal component analysis (PCA) were performed with log2–transformed values. (a) PCA plots of transcriptomic data of BM, blood and tumor neutrophils respectively. (b) Heat map of the differentially expressed genes selected with Benjamini–Hochberg adjusted p-values < 0.05. Four gene clusters (1 to 4) were manually defined and exported for gene ontology (GO) biological process analysis. (c) GO biological process terms enriched in clusters 1 (left) and 4 (right). (d,e) Expression of genes with row/gene-based z-score values (log2 FPKM) of cluster 4-associated genes across all sorted populations encoding (d) GO: 0006096—Glycolytic process and (e) GO: 0071456—Cellular response to hypoxia. (f) Representative immunofluorescence staining of pancreas sections from OT mice stained with Dapi (blue), S100A9 (red) neutrophil marker, and HIF-1α (green) and GLUT1 (cyan) glycolytic markers. Immunofluorescence images shown are representative images of n = 3 mice, and 10–15 fields of view. Scale bar = 100 µM. Scatter plots represent the mean fluorescence intensity (MFI) of HIF-1α+ neutrophils staining in the nucleus and cytoplasm, and percentage of GLUT1 expressing neutrophils in the tumor. Data represent the means ± SEM, *** p < 0.001 by unpaired Student’s t-test with a 95% confidence interval.
Figure 2 Pro-tumoral neutrophils exhibit a highly glycolytic signature and are adapted to a hypoxic tumor microenvironment (a–e) Bone marrow (BM), blood and tumor neutrophils were sorted based on their expression of Dapi-CD45 + Lin(CD3/B220/NK1.1) − Ly6G + Ly6C+ (orthotopic transplanted [OT] n = 5 mice pooled, three independent experiments). Hierarchical clustering and principal component analysis (PCA) were performed with log2–transformed values. (a) PCA plots of transcriptomic data of BM, blood and tumor neutrophils respectively. (b) Heat map of the differentially expressed genes selected with Benjamini–Hochberg adjusted p-values < 0.05. Four gene clusters (1 to 4) were manually defined and exported for gene ontology (GO) biological process analysis. (c) GO biological process terms enriched in clusters 1 (left) and 4 (right). (d,e) Expression of genes with row/gene-based z-score values (log2 FPKM) of cluster 4-associated genes across all sorted populations encoding (d) GO: 0006096—Glycolytic process and (e) GO: 0071456—Cellular response to hypoxia. (f) Representative immunofluorescence staining of pancreas sections from OT mice stained with Dapi (blue), S100A9 (red) neutrophil marker, and HIF-1α (green) and GLUT1 (cyan) glycolytic markers. Immunofluorescence images shown are representative images of n = 3 mice, and 10–15 fields of view. Scale bar = 100 µM. Scatter plots represent the mean fluorescence intensity (MFI) of HIF-1α+ neutrophils staining in the nucleus and cytoplasm, and percentage of GLUT1 expressing neutrophils in the tumor. Data represent the means ± SEM, *** p < 0.001 by unpaired Student’s t-test with a 95% confidence interval.CC BY · PubMed Central
Figure 3 High influx of tumor-infiltrating neutrophils expressing HIF-1α and glycolytic markers in PDAC patients (a) A sequential, multiplex, immunofluorescence staining panel consisting of a neutrophil marker (CD15), pancreatic epithelial cell marker (CK), and metabolic markers (HIF-1α, GLUT1 and HK2) was used to stain formalin-fixed paraffin-embedded pancreatic sections obtained from multi-center patient cohorts. Images are representative of matched normal adjacent tissue (n = 13) and PDAC patient tumor tissue (n = 42). Dapi (blue), CK (cyan), CD15 (red), HIF-1α (white), HK2 (magenta), GLUT1 (orange). Scale bar = 100 µM. (b) Scatter plot showing the total influx of neutrophils in PDAC patient sections (blue clear) compared to matched normal controls (black clear) as a % of total Dapi+ cells. (c–e) The expression of multiple metabolic markers was quantified using Inform Software and assessed in PDAC patient tissue compared to adjacent matched normal control tissue. (c) Scatter plots represent the expression of triple positive HIF-1α + GLUT1 + HK2+ subset as a percentage of total CD15+ neutrophils. (d) Scatter plots indicate the proportions of double positive HIF-1α + GLUT1+, HIF-1α + HK2+ and GLUT1 + HK2+ neutrophils. (e) Scatter plots indicate the proportions of HIF-1α+, GLUT1+ and HK2+ cells as a percentage of total CD15+ neutrophils. Data represent the means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by unpaired Student’s t-test with a 95% confidence interval.
Figure 3 High influx of tumor-infiltrating neutrophils expressing HIF-1α and glycolytic markers in PDAC patients (a) A sequential, multiplex, immunofluorescence staining panel consisting of a neutrophil marker (CD15), pancreatic epithelial cell marker (CK), and metabolic markers (HIF-1α, GLUT1 and HK2) was used to stain formalin-fixed paraffin-embedded pancreatic sections obtained from multi-center patient cohorts. Images are representative of matched normal adjacent tissue (n = 13) and PDAC patient tumor tissue (n = 42). Dapi (blue), CK (cyan), CD15 (red), HIF-1α (white), HK2 (magenta), GLUT1 (orange). Scale bar = 100 µM. (b) Scatter plot showing the total influx of neutrophils in PDAC patient sections (blue clear) compared to matched normal controls (black clear) as a % of total Dapi+ cells. (c–e) The expression of multiple metabolic markers was quantified using Inform Software and assessed in PDAC patient tissue compared to adjacent matched normal control tissue. (c) Scatter plots represent the expression of triple positive HIF-1α + GLUT1 + HK2+ subset as a percentage of total CD15+ neutrophils. (d) Scatter plots indicate the proportions of double positive HIF-1α + GLUT1+, HIF-1α + HK2+ and GLUT1 + HK2+ neutrophils. (e) Scatter plots indicate the proportions of HIF-1α+, GLUT1+ and HK2+ cells as a percentage of total CD15+ neutrophils. Data represent the means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by unpaired Student’s t-test with a 95% confidence interval.CC BY · PubMed Central
Figure 4 Neutrophil-specific HIF-1α deletion significantly attenuates tumor burden (a) Pancreatic tumors from tumor-bearing HIF-1αΔNφ orthotopic transplanted (OT) and littermate HIF-1αfl/fl control OT mice were harvested at day 28 post transplantation and the myeloid cell populations were assessed by flow cytometry. The scatter plot of infiltrating neutrophils (Dapi-CD45 + Lin(CD3/B220/NK1.1) − Ly6G + Ly6C+) are plotted as a percentage of total CD45+ cells, from HIF-1αΔNφ OT mice (red clear) and littermate HIF-1αfl/fl controls (black clear) (OT n = 23, sham n = 14; of three independent experiments, pooled). (b) Pancreatic neutrophils were sorted from HIF-1αΔNφ mice and littermate controls and gene expression of CCL2 and CCL3 was assessed by quantitative PCR (n = 3 mice, three independent experiments). (c) Sorted neutrophils from HIF-1αΔNφ OT and control OT mice were rested at 37 °C for 1 h and assessed for their glycolytic capacity by live metabolic flux assay. A representative Seahorse extracellular acidification rate (ECAR) trace of HIF-1αΔNφ OT neutrophils (red) compared with control OT neutrophils (black) is shown (left). The glycolytic capacity (right) was calculated from the Seahorse ECAR trace (n = 3–5 mice pooled per group, three independent experiments). (d) Orthotopic tumors from HIF-1αΔNφ OT and control OT mice were monitored in vivo over time by bioluminescent imaging (BLI; left). The total flux (right) on day 27 post transplantation was calculated from the BLI image (control, n = 25; HIF-1αΔNφ, n = 34, three independent experiments pooled). BLI images were acquired at a 15-s exposure, and the color scale was set to a lower limit of 3 × 106 and an upper limit of 5 × 107 photons/sec. (e) Representative images of HIF-1αΔNφ OT and control OT mice tumors. (f) Tumors were harvested on day 27 post transplantation and weighed. Scatter plot of orthotopic tumor weights from HIF-1αΔNφ OT (red clear) and age-matched OT controls (black clear) (HIF-1αΔNφ n = 24, controls n = 17; of four independent experiments pooled). (g) Kaplan–Meier survival analysis of HIF-1αΔNφ OT mice (n = 25) compared with littermate HIF-1αfl/fl control OT mice (n = 12). Data represent the means ± SEM, * p < 0.05; *** p < 0.001 by unpaired student’s t-test with a 95% confidence interval.
Figure 4 Neutrophil-specific HIF-1α deletion significantly attenuates tumor burden (a) Pancreatic tumors from tumor-bearing HIF-1αΔNφ orthotopic transplanted (OT) and littermate HIF-1αfl/fl control OT mice were harvested at day 28 post transplantation and the myeloid cell populations were assessed by flow cytometry. The scatter plot of infiltrating neutrophils (Dapi-CD45 + Lin(CD3/B220/NK1.1) − Ly6G + Ly6C+) are plotted as a percentage of total CD45+ cells, from HIF-1αΔNφ OT mice (red clear) and littermate HIF-1αfl/fl controls (black clear) (OT n = 23, sham n = 14; of three independent experiments, pooled). (b) Pancreatic neutrophils were sorted from HIF-1αΔNφ mice and littermate controls and gene expression of CCL2 and CCL3 was assessed by quantitative PCR (n = 3 mice, three independent experiments). (c) Sorted neutrophils from HIF-1αΔNφ OT and control OT mice were rested at 37 °C for 1 h and assessed for their glycolytic capacity by live metabolic flux assay. A representative Seahorse extracellular acidification rate (ECAR) trace of HIF-1αΔNφ OT neutrophils (red) compared with control OT neutrophils (black) is shown (left). The glycolytic capacity (right) was calculated from the Seahorse ECAR trace (n = 3–5 mice pooled per group, three independent experiments). (d) Orthotopic tumors from HIF-1αΔNφ OT and control OT mice were monitored in vivo over time by bioluminescent imaging (BLI; left). The total flux (right) on day 27 post transplantation was calculated from the BLI image (control, n = 25; HIF-1αΔNφ, n = 34, three independent experiments pooled). BLI images were acquired at a 15-s exposure, and the color scale was set to a lower limit of 3 × 106 and an upper limit of 5 × 107 photons/sec. (e) Representative images of HIF-1αΔNφ OT and control OT mice tumors. (f) Tumors were harvested on day 27 post transplantation and weighed. Scatter plot of orthotopic tumor weights from HIF-1αΔNφ OT (red clear) and age-matched OT controls (black clear) (HIF-1αΔNφ n = 24, controls n = 17; of four independent experiments pooled). (g) Kaplan–Meier survival analysis of HIF-1αΔNφ OT mice (n = 25) compared with littermate HIF-1αfl/fl control OT mice (n = 12). Data represent the means ± SEM, * p < 0.05; *** p < 0.001 by unpaired student’s t-test with a 95% confidence interval.CC BY · PubMed Central
Figure 5 HIF-1αΔNφ neutrophils exert direct anti-tumoral effects (a) Scatter plot of reactive oxygen species (ROS) production (MFI) in HIF-1αΔNφ orthotopic transplanted (OT) and control OT pancreatic neutrophils (HIF-1αΔNφ n = 12 mice, littermate HIF-1αfl/fl controls n = 10; three independent experiments). (b) Neutrophils were sorted based on their expression of Dapi-CD45 + Lin(CD3/B220/NK1.1) − Ly6G + Ly6C+. Scatter plot shown indicates the cytotoxic capacity of HIF-1αΔNφ neutrophils at a 10:1 effector:target (E:T) cell ratio after 2, 4 and 6 h incubation with 1242 L tumor cells (n = 5 mice/group; n = 3 replicates). (c) HIF-1αΔNφ neutrophils were assessed for their cytotoxic capacity via ROS production. Neutrophils were treated with 5 mM N-acetyl-L-cysteine for 30 min at 37 °C. Scatter plot shown indicates the cytotoxic capacity of HIF-1αΔNφ neutrophils at a 10:1 E:T ratio after 4 h incubation with 1242 L tumor cells (n = 5 mice/group; n = 3 replicates). Data represent the means ± SEM, * p < 0.05; *** p < 0.001 by unpaired Student’s t-test with 95% confidence interval.
Figure 5 HIF-1αΔNφ neutrophils exert direct anti-tumoral effects (a) Scatter plot of reactive oxygen species (ROS) production (MFI) in HIF-1αΔNφ orthotopic transplanted (OT) and control OT pancreatic neutrophils (HIF-1αΔNφ n = 12 mice, littermate HIF-1αfl/fl controls n = 10; three independent experiments). (b) Neutrophils were sorted based on their expression of Dapi-CD45 + Lin(CD3/B220/NK1.1) − Ly6G + Ly6C+. Scatter plot shown indicates the cytotoxic capacity of HIF-1αΔNφ neutrophils at a 10:1 effector:target (E:T) cell ratio after 2, 4 and 6 h incubation with 1242 L tumor cells (n = 5 mice/group; n = 3 replicates). (c) HIF-1αΔNφ neutrophils were assessed for their cytotoxic capacity via ROS production. Neutrophils were treated with 5 mM N-acetyl-L-cysteine for 30 min at 37 °C. Scatter plot shown indicates the cytotoxic capacity of HIF-1αΔNφ neutrophils at a 10:1 E:T ratio after 4 h incubation with 1242 L tumor cells (n = 5 mice/group; n = 3 replicates). Data represent the means ± SEM, * p < 0.05; *** p < 0.001 by unpaired Student’s t-test with 95% confidence interval.CC BY · PubMed Central
Figure 6 Anti-tumoral effector responses are supported by CD8+ T cells and NK cells activation and cytotoxicity (a) Bone marrow (BM), blood and tumor neutrophils were sorted based on their expression of Dapi-CD45 + Lin (CD3/B220/NK1.1) − Ly6G + Ly6C+ (orthotopic transplanted [OT] n = 5 mice pooled, three independent experiments). Gene analysis of Arg-1 was analyzed with log2-transformed values (log2RPKM). Data represent the means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by one-way ANOVA, Tukey’s multiple comparisons test with a 95% confidence interval. (b) Pancreatic neutrophils were sorted from HIF-1αΔNφ and control mice, and gene expression of Ag1, (c) IL-12 and CCL5 was assessed by quantitative PCR (n = 3 mice, three independent experiments). (d) Representative flow cytometry plots from HIF-1αΔNφ and control neutrophils. Neutrophils were stimulated with 100 ng/mL LPS for 4 h and assessed for IL-12 and (e) TNF-α production by flow cytometry. Scatter plots indicate the percentage of total Ly6G+ cells, from HIF-1αΔNφ OT (red clear) and age-matched OT controls (black clear) (HIF-1αΔNφ n = 12, controls n = 10; of two independent experiments pooled). Data represent the means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by unpaired Student’s t-test with 95% confidence interval.
Figure 6 Anti-tumoral effector responses are supported by CD8+ T cells and NK cells activation and cytotoxicity (a) Bone marrow (BM), blood and tumor neutrophils were sorted based on their expression of Dapi-CD45 + Lin (CD3/B220/NK1.1) − Ly6G + Ly6C+ (orthotopic transplanted [OT] n = 5 mice pooled, three independent experiments). Gene analysis of Arg-1 was analyzed with log2-transformed values (log2RPKM). Data represent the means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by one-way ANOVA, Tukey’s multiple comparisons test with a 95% confidence interval. (b) Pancreatic neutrophils were sorted from HIF-1αΔNφ and control mice, and gene expression of Ag1, (c) IL-12 and CCL5 was assessed by quantitative PCR (n = 3 mice, three independent experiments). (d) Representative flow cytometry plots from HIF-1αΔNφ and control neutrophils. Neutrophils were stimulated with 100 ng/mL LPS for 4 h and assessed for IL-12 and (e) TNF-α production by flow cytometry. Scatter plots indicate the percentage of total Ly6G+ cells, from HIF-1αΔNφ OT (red clear) and age-matched OT controls (black clear) (HIF-1αΔNφ n = 12, controls n = 10; of two independent experiments pooled). Data represent the means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by unpaired Student’s t-test with 95% confidence interval.CC BY · PubMed Central
Figure 7 Anti-tumoral effector responses are supported by CD8+ T cells and NK cells activation and cytotoxicity. (a–e) Flow cytometry was performed in HIF-1αΔNφ orthotopic transplanted (OT) and littermate HIF-1αfl/fl control mice to assess cytotoxic T lymphocytes (CTL) and natural killer (NK) cell populations. CTL are gated based on their expression of CD45 + CD90.2 + CD3 + CD8+ and NK cells are gated based on their expression of CD45 + CD90.2-CD19-NK1.1+. Shown are scatter plots of (a) the % CD3 + CD8+ T cells, and (b) % NK cells of the total CD45+ population in the pancreata of HIF-1αΔNφ OT (red clear) and control OT (black clear) mice (HIF-1αΔNφ n = 22, control n = 14 mice per group, pooled from three independent experiments). CTL and NK cells were stimulated with 10 ng/mL PMA and 1 µM ionomycin for 4 h. Scatter plots indicate the percentage (c) Perforin+, (d) Granzyme B+, and (e) IFN-γ+ cells of total CTL and NK cells in the pancreata of HIF-1αΔNφ OT (red clear) and control OT (black clear) mice (HIF-1αΔNφ n = 22, control n = 14 mice per group, pooled from three independent experiments). Data represent the means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by unpaired Student’s t-test with a 95% confidence interval.
Figure 7 Anti-tumoral effector responses are supported by CD8+ T cells and NK cells activation and cytotoxicity. (a–e) Flow cytometry was performed in HIF-1αΔNφ orthotopic transplanted (OT) and littermate HIF-1αfl/fl control mice to assess cytotoxic T lymphocytes (CTL) and natural killer (NK) cell populations. CTL are gated based on their expression of CD45 + CD90.2 + CD3 + CD8+ and NK cells are gated based on their expression of CD45 + CD90.2-CD19-NK1.1+. Shown are scatter plots of (a) the % CD3 + CD8+ T cells, and (b) % NK cells of the total CD45+ population in the pancreata of HIF-1αΔNφ OT (red clear) and control OT (black clear) mice (HIF-1αΔNφ n = 22, control n = 14 mice per group, pooled from three independent experiments). CTL and NK cells were stimulated with 10 ng/mL PMA and 1 µM ionomycin for 4 h. Scatter plots indicate the percentage (c) Perforin+, (d) Granzyme B+, and (e) IFN-γ+ cells of total CTL and NK cells in the pancreata of HIF-1αΔNφ OT (red clear) and control OT (black clear) mice (HIF-1αΔNφ n = 22, control n = 14 mice per group, pooled from three independent experiments). Data represent the means ± SEM, * p < 0.05; ** p < 0.01; *** p < 0.001 by unpaired Student’s t-test with a 95% confidence interval.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 28

Metadata

Authors
Sieow, J. L., Penny, H. L., Gun, S. Y., Tan, L. Q., Duan, K., Yeong, J. P. S., Pang, A., Lim, D., Toh, H. C., Lim, T. K. H., Engleman, E., Rotzschke, O., Ng, L. G., Chen, J., Tan, S. M., & Wong, S. C.
Affiliations
  • Agency for Science, Technology and Research (SG)
  • National University Cancer Institute, Singapore (SG)
  • National University Health System (SG)
  • National Cancer Centre Singapore (SG)
  • Singapore General Hospital (SG)
  • Stanford Medicine (US)
  • Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore
  • Nanyang Technological University (SG)
Corresponding author
Wong, Siew Cheng
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2023-01-01
Volume
24
Issue
1
Pages
753
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4313472601
Cited by
27
References
72
Citations by year
2026: 7 · 2025: 5 · 2024: 13 · 2023: 2
FWCI
3.07
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DR-NTU (Nanyang Technological University) (submittedVersion, cc-by)
  • National University of Singapore (submittedVersion)
Funders
  • Biomedical Research Council
  • A*STAR
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Keywords
hypoxia-inducible factor-1α, tumor-infiltrating neutrophils, pancreatic ductal adenocarcinoma, neutrophil metabolism, glycolysis, tumor microenvironment, neutrophil reprogramming, reactive oxygen species, natural killer cells, CD8+ T cells, tumor immunology, metabolic cancer therapy
MeSH terms
Animals, Humans, Neutrophils, Pancreatic Neoplasms, Mice, Knockout, Carcinoma, Pancreatic Ductal, Cell Line, Tumor, Mice, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit, Tumor Microenvironment, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.